510(k) Report

510(k) · Cleared

Cleared

Cobas Integra Alp Ifcc Gen.2

K033185510(k) SpecialCleared Oct 14, 200313-day reviewClass II21 CFR 862.1050

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Roche Diagnostics Corp. · CJE Nitrophenylphosphate, Alkaline Phosphatase Or Isoenzymes

Cleared on Oct 14, 2003 as substantially equivalent to K981897 (Roche Diagnostic Systems, Inc., 1998) after a 13-day review. Its family tree reaches back 2 generations to 1989. 3 later devices descend from it.

Decided
Oct 14, 2003
Review
13 days
Class
Class II
Product code
CJE
Recalls
None
Predicates
1

Its longest line of descent runs back 2 generations to K895880 (1989). 3 ancestors in all. 3 later devices descend from it, 2 citing it directly.

Other ancestors, by year clearedDescendants, by year cleared 1995: 1 other ancestor2017: 1 descendant cleared2011: 1 descendant cleared2019: 1 descendant clearedK895880 · Pancreatic a-Amylase Eps · Boehringer Mannheim Corp. · 1989K981897 · Roche Cobas Integra Alkaline Phosphatase Ifcc Liquid Reagent Cassette, Roche Cobas Integra Pancreatic a-Amylase Eps Reae · Roche Diagnostic Systems, Inc. · 19981990200020102020
Other ancestors, by generationDescendants, by generation 2 generations back: 1 other ancestor 1 generation forward: 2 descendants2 generations forward: 1 descendant K981897 · Roche Cobas Integra Alkaline Phosphatase Ifcc Liquid Reagent Cassette, Roche Cobas Integra Pancreatic a-Amylase Eps Reae · Roche Diagnostic Systems, Inc. · 1998K895880 · Pancreatic a-Amylase Eps · Boehringer Mannheim Corp. · 19890
  1. Root · 2 generations backK895880 Pancreatic a-Amylase EpsBoehringer Mannheim Corp. · 1989
  2. 1 generation backK981897 Roche Cobas Integra Alkaline Phosphatase Ifcc Liquid Reagent…Roche Diagnostic Systems, Inc. · 1998
  3. This deviceK033185 Cobas Integra Alp Ifcc Gen.2Roche Diagnostics Corp. · 2003
  4. Descendant · cites it directly · 1 of its ownK171080 ALP IFCC Gen.2Roche Diagnostics Operations (Rdo) · 2017
  5. Descendant · 2 generations on · 0 of its ownK191245 Yumizen C1200 ALP, Yumizen C1200 AlbuminHoriba Abx Sas · 2019
  6. Descendant · cites it directly · 0 of its ownK113269 Elittech Clinical Systems Alp Ifcc SLElitechgroup · 2011

Most influential descendants

Showing 3 of 3 · See all
  • K171080ALP IFCC Gen.2Roche Diagnostics Operations (Rdo) · 2017 · cites it directly1descendant
  • K191245Yumizen C1200 ALP, Yumizen C1200 AlbuminHoriba Abx Sas · 2019 · 2 generations on0descendants
  • K113269Elittech Clinical Systems Alp Ifcc SLElitechgroup · 2011 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−2K895880Pancreatic a-Amylase EpsBoehringer Mannheim Corp.1989—
−1K981897Roche Cobas Integra Alkaline Phosphatase Ifcc Liquid Reagent Cassette, Roche…Roche Diagnostic Systems, Inc.1998—
0 (this device)K033185Cobas Integra Alp Ifcc Gen.2Roche Diagnostics Corp.2003—
+1K171080ALP IFCC Gen.2Roche Diagnostics Operations (Rdo)2017—
+2K191245Yumizen C1200 ALP, Yumizen C1200 AlbuminHoriba Abx Sas2019—
+1K113269Elittech Clinical Systems Alp Ifcc SLElitechgroup2011—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199510

Descendants by year cleared

Year clearedDevicesWith a Class I recall
201110
201710
201910
FIG. 1 — Lineage of K033185, 1989–2019Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in CJE? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new CJE device

  1. #1 K251074 Tru Liver Health Test Panelscore 10.8 · 2 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K981897Roche Cobas Integra Alkaline Phosphatase Ifcc Liquid Reagent Cassette, Roche Cobas…
Summary page 2
…COBAS Integra ALP IFCC Gen.2, continued Predicate We claim substantial equivalence to the currently marketed COBAS Integra Device ALP IFCC Assay. (K98 1897). Reagent The following table describes the similarities and differences between the Summary COBAS Integr…
Roche Diagnostic Systems, Inc.1998—

Also cleared against K981897: 2 other devices →

What descends from it? (3)

2 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K171080ALP IFCC Gen.2Roche Diagnostics Operations (Rdo)20171
K113269Elittech Clinical Systems Alp Ifcc SLElitechgroup20110

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 14 years and passes through 3 companies; a new generation was cleared every 8.7 years on median.
  • 1 of the 3 ancestors has a recall of any class.
  • Of its descendants, K171080 (Roche Diagnostics Operations (Rdo), 2017) has gone furthest, with 1 descendant of its own.
  • 2 other devices also cite its predicate K981897.

How does its category compare?

All CJE devices

CJE Nitrophenylphosphate, Alkaline Phosphatase Or Isoenzymes: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · CJE

1in 2025

2008: 12011: 22012: 12013: 22017: 22018: 12019: 12023: 12024: 12025: 1
2007high 2 (2011) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · CJE

Too few CJE 510(k)s in any year since 2007 to give a median.

Recalls per year · CJE

1in 2013

2008: 82011: 12013: 1
2007high 8 (2008) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · CJE

10in 2025

2010: 32011: 242019: 12020: 12021: 12022: 62023: 112024: 112025: 10
2007high 24 (2011) · low 0 (2007)2025

MAUDE reports naming product code CJE, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20081—80
20090—00
20100—03
20112—124
20121—00
20132—10
20140—00
20150—00
20160—00
20172—00
20181—00
20191—01
20200—01
20210—01
20220—06
20231—011
20241—011
20251—010
20260—0—

What is it indicated for?

The cassettes COBAS Integra ALP IFCC Gen.2 Small (ALP2S) and COBAS Integra ALP IFCC Gen.2 Large (ALP2L) contain an in vitro diagnostic reagent system intended for use on COBAS Integra systems for the quantitative determination of the catalytic activity of alkaline phosphatase in human serum and plasma. Measurements of alkaline phosphatase or its isoenzymes are used in the diagnosis and treatment of liver, bone, parathyroid, and intestinal diseases.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K033185: Cobas Integra Alp Ifcc Gen.2.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 3, 2026. https://510kreport.com/device/K033185

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026